Ying Zhang
Patent Dept Head, Founding Partner
IPSunny International Law
Personal Profile
Personal Profile
Domestic and international patent layout, construction of patent pools, writing of difficult cases, analysis of patent stability, analysis of authorization prospects, FTO analysis, reexamination, invalidity, infringement and other matters
I started working in patent related fields in 2003 and worked as a senior patent agent in a foreign agency for 11 years. In 2018, I co founded Beijing Ruiyang United Intellectual Property Agency Co., Ltd. with other partners;
Specializes in various fields including biopharmaceuticals, chemical drugs, formulations, synthetic biology, immunology, biomedicine, IVD diagnosis, gene therapy, cell therapy, stem cells, next-generation sequencing, etc.
Main clients served:
Wyeth Pharmaceuticals, Roche Pharmaceuticals, Astellas Pharmaceuticals, Kyocera Fermentation Kirin, Fresenius, Baxter, OSI American Pharmaceutical Company, Otsuka Pharmaceuticals, Borui Pasteur, 3M, L'Oreal, Beijing Institute of Life Sciences, Yangtze River Pharmaceutical, Yabao Pharmaceutical, Hisilicon Pharmaceutical, Yuanda Pharmaceutical, Dongyangguang Pharmaceutical Group, Beijing Kexing Zhongwei, Shijiazhuang Yiling Pharmaceutical Group, Kemei Diagnostics, Mike Biotech, Fengyuan Group, etc.
Previously led teams or participated as key personnel in ineffective and infringement cases:
Erlotinib hydrochloride (Trokai, representing Roche); Hydroxyethyl starch as a substitute for plasma; Citric acid (China Patent Gold Award patent, representing the patent owner); Cetirizine; Biotin, idosaban methanesulfonate; Dapagliflozin; Jiafuming and Vidagliptin; En he Capone; Methanesulfonic acid sulfonamide; Biotin; Cellulase; Phytase; Cases involving sodium picosulfate and others.
Domestic and international patent layout, construction of patent pools, writing of difficult cases, analysis of patent stability, analysis of authorization prospects, FTO analysis, reexamination, invalidity, infringement and other matters
I started working in patent related fields in 2003 and worked as a senior patent agent in a foreign agency for 11 years. In 2018, I co founded Beijing Ruiyang United Intellectual Property Agency Co., Ltd. with other partners;
Specializes in various fields including biopharmaceuticals, chemical drugs, formulations, synthetic biology, immunology, biomedicine, IVD diagnosis, gene therapy, cell therapy, stem cells, next-generation sequencing, etc.
Main clients served:
Wyeth Pharmaceuticals, Roche Pharmaceuticals, Astellas Pharmaceuticals, Kyocera Fermentation Kirin, Fresenius, Baxter, OSI American Pharmaceutical Company, Otsuka Pharmaceuticals, Borui Pasteur, 3M, L'Oreal, Beijing Institute of Life Sciences, Yangtze River Pharmaceutical, Yabao Pharmaceutical, Hisilicon Pharmaceutical, Yuanda Pharmaceutical, Dongyangguang Pharmaceutical Group, Beijing Kexing Zhongwei, Shijiazhuang Yiling Pharmaceutical Group, Kemei Diagnostics, Mike Biotech, Fengyuan Group, etc.
Previously led teams or participated as key personnel in ineffective and infringement cases:
Erlotinib hydrochloride (Trokai, representing Roche); Hydroxyethyl starch as a substitute for plasma; Citric acid (China Patent Gold Award patent, representing the patent owner); Cetirizine; Biotin, idosaban methanesulfonate; Dapagliflozin; Jiafuming and Vidagliptin; En he Capone; Methanesulfonic acid sulfonamide; Biotin; Cellulase; Phytase; Cases involving sodium picosulfate and others.
